Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features

OBJECTIVE: To report the experience of a single center for the selection of radioiodine-refractory (RAIR) thyroid cancer patients (RAIR-TC) who needed tyrosine kinase inhibitor (TKIs) treatment. PATIENTS AND METHODS: We evaluated all features of 279 RAIR-TC patients both at the time of diagnosis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorusso, L., Minaldi, E., Esposito, G., Piaggi, P., Bottici, V., Brogioni, S., Giani, C., Valerio, L., Molinaro, E., Elisei, R., Agate, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514097/
https://www.ncbi.nlm.nih.gov/pubmed/37084131
http://dx.doi.org/10.1007/s40618-023-02076-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514097/
https://www.ncbi.nlm.nih.gov/pubmed/37084131
http://dx.doi.org/10.1007/s40618-023-02076-6

Ejemplares similares